By InvitationNot Applicable

Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry

United States100,000 participantsStarted 2021-10-29

Plain-language summary

The purpose of this research is to learn more about the impact of genetic testing on healthcare costs, clinical care, and quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Tapestry patients who have received genetic results, regardless of positive or negative testing results. * Age of 18 and older. * Patients with an established Mayo Clinic provider prior to their enrollment in Tapestry. Exclusion Criteria: * Individuals less than 18 years old. * Patients without capacity to consent (i.e., needing legal authorized representatives). * Prisoners. * Subjects eligible for chart review, without a Minnesota Research Authorization on record.

What they're measuring

Change in quality of life measured through adjusted years.

Timeframe: Every 12 months for 5 years after enrollment.

Disease incidence measured by disease count per 100 participants.

Timeframe: 12 months

Change in utilization measured by total number of office visits, hospital stays, ER visits, and length of visits.

Timeframe: Every 12 months for 5 years after enrollment.

Change in costs measured by disease related and all-cost related costs.

Timeframe: Every 12 months for 5 years after enrollment.

Trial details

NCT IDNCT05045222

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2031-07-31

View on ClinicalTrials.gov More Health Care Utilization trials